18337-63-8 Usage
General Description
4(1H)-Pyrimidinone, 6-hydroxy-5-methyl- (8CI,9CI) is a technical classification of a specific type of pyrimidinone, which is a type of molecule that has a large variety of uses in organic chemistry and biochemistry. 4(1H)-Pyrimidinone, 6-hydroxy-5-methyl- (8CI,9CI) is a derivative of pyrimidinone, a heterocyclic aromatic organic compound similar to pyrimidine. As suggested by the name, it is distinguished by a hydroxyl and a methyl group attached at the 6th and 5th positions of the pyrimidinone core, respectively. Its specific functions and uses can vary widely depending on the context, often being used as an intermediate in the synthesis of more complex organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 18337-63-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,8,3,3 and 7 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 18337-63:
(7*1)+(6*8)+(5*3)+(4*3)+(3*7)+(2*6)+(1*3)=118
118 % 10 = 8
So 18337-63-8 is a valid CAS Registry Number.
InChI:InChI=1/C5H6N2O2/c1-3-4(8)6-2-7-5(3)9/h2H,1H3,(H2,6,7,8,9)
18337-63-8Relevant articles and documents
Synthesis of new 5-substituted pyrimidine acyclonucleosides
Khattab, Ahmed F.
, p. 1097 - 1107 (2007/10/03)
Acyclonucleosides of pyrimidine were prepared by condensing appropriately silylated 5-substituted pyrimidines with an acyclic side chain in the form of an acetylated haloalkoxyalcohol and subsequent removal of the protecting acetyl group in base. Also, ac
Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same
-
Page/Page column 19, (2008/06/13)
A subject of the invention is the compounds of formula (I): in which R1, R2, R3, R4 and G have the meanings indicated in the description, their preparation process, their use as medicaments having an antagonist activity on the vitronectin receptor and the pharmaceutical compositions containing them.
